Published in Nat New Biol on July 28, 1971
Method for correlation of proton magnetic resonance assignments in different solvents: conformational transition of oxytocin and lysine vasopressin from dimethylsulfoxide to water. Proc Natl Acad Sci U S A (1972) 1.10
Nuclear magnetic resonance spectrum of lysine-vasopressin in aqueous solution and its structural implictions. Proc Natl Acad Sci U S A (1972) 1.04
Relative conformational rigidity in oxytocin and (1-penicillamine)-oxytocin: a proposal for the relationship of conformational flexibility to peptide hormone agonism and antagonism. Proc Natl Acad Sci U S A (1977) 0.95
300-MHz nuclear magnetic resonance study of oxytocin aqueous solution: conformational implications. Proc Natl Acad Sci U S A (1973) 0.87
Nuclear magnetic resonance spectrum of deamino-lysine-vasopression in aqueous solution and its structural implications. Proc Natl Acad Sci U S A (1972) 0.75
Conformational studies on arginine vasopressin and arginine vasotocin by proton magnetic resonance spectroscopy. Proc Natl Acad Sci U S A (1974) 0.75
Pirenzepine distinguishes between different subclasses of muscarinic receptors. Nature (1980) 5.39
The binding of agonists to brain muscarinic receptors. Mol Pharmacol (1978) 3.17
Effects of adrenaline on human blood platelets. J Physiol (1967) 2.38
The binding of antagonists to brain muscarinic receptors. Mol Pharmacol (1978) 2.35
Role of an inhibitory pyrimidine element and polypyrimidine tract binding protein in repression of a regulated alpha-tropomyosin exon. RNA (1998) 2.18
The proton relaxation of benzyl alcohol in erythrocyte membranes. Mol Pharmacol (1968) 2.17
The plurality of long chain isoprenoid alcohols (polyprenols) from natural sources. Biochim Biophys Acta (1967) 2.07
The release of nucleotides, 5-hydroxytryptamine and enzymes from human blood platelets during aggregation. J Physiol (1968) 1.97
Smooth muscle-specific switching of alpha-tropomyosin mutually exclusive exon selection by specific inhibition of the strong default exon. EMBO J (1994) 1.91
Nuclear magnetic resonance spectroscopy of amino acids, peptides, and proteins. Adv Protein Chem (1970) 1.89
Inhibitory and blocking monoclonal antibody epitopes on merozoite surface protein 1 of the malaria parasite Plasmodium falciparum. J Mol Biol (2001) 1.87
Intracellular calcium measurements by 19F NMR of fluorine-labeled chelators. Proc Natl Acad Sci U S A (1983) 1.77
Modification of the binding properties of muscarinic receptors by gallamine. Mol Pharmacol (1983) 1.73
Nuclear magnetic resonance spectrometry of naturally occurring polyprenols. Anal Biochem (1967) 1.63
The binding of (3H)-propylbenzilycholine mustard by longitudinal muscle strips from guinea-pig small intestine. Br J Pharmacol (1974) 1.62
Solution structure of an EGF module pair from the Plasmodium falciparum merozoite surface protein 1. J Mol Biol (1999) 1.61
The uptake of isoprenaline and noradrenaline by the perfused rat heart. Mol Pharmacol (1966) 1.61
The mechanism of action of ribonuclease. Proc Natl Acad Sci U S A (1969) 1.51
Mapping the binding site for matrix metalloproteinase on the N-terminal domain of the tissue inhibitor of metalloproteinases-2 by NMR chemical shift perturbation. Biochemistry (1997) 1.50
Binding of agonists and antagonists to muscarinic receptors. J Supramol Struct (1976) 1.50
Binding of flexible ligands to macromolecules. Nature (1975) 1.45
Ischemic sinus node hibernation: resolution following angioplasty. Am Heart J (1991) 1.43
Equine anti-hapten antibody. 3. The comparative properties of gamma G- and gammaA-antibodies. J Immunol (1966) 1.43
Photolabile precursors of inositol phosphates. Preparation and properties of 1-(2-nitrophenyl)ethyl esters of myo-inositol 1,4,5-trisphosphate. Biochemistry (1989) 1.43
Guanine nucleotides modulate muscarinic receptor binding in the heart. Biochem Biophys Res Commun (1979) 1.42
Influence of globin structure on the state of the heme. II. Allosteric transitions in methemoglobin. Biochemistry (1974) 1.40
Correction for light absorption in fluorescence studies of protein-ligand interactions. Anal Biochem (1983) 1.40
Frontal lobe volume in patients with Huntington's disease. Neurology (1998) 1.38
Influences on the ethical beliefs of graduate students concerning research. Sci Eng Ethics (2001) 1.37
Homologues of benzilylcholine mustard. J Pharm Pharmacol (1972) 1.35
Mobility of polypeptide chain in the pyruvate dehydrogenase complex revealed by proton NMR. Nature (1981) 1.35
The catalytic mechanism of cytochrome P450 BM3 involves a 6 A movement of the bound substrate on reduction. Nat Struct Biol (1996) 1.32
Equine antihapten antibody. The molecular weights of the subunits of equine immunoglobulins. Biochemistry (1969) 1.31
The catalytic mechanism of beta-lactamases: NMR titration of an active-site lysine residue of the TEM-1 enzyme. Proc Natl Acad Sci U S A (1996) 1.26
Skin sensitizing antibodies: a comparative study of canine and human PK and PCA antibodies and a canine myeloma protein. J Immunol (1967) 1.25
The conformation of acetylcholine and related compounds in aqueous solution as studied by nuclear magnetic resonance spectroscopy. Mol Pharmacol (1972) 1.24
Large-scale purification and characterization of dihydrofolate reductase from a methotrexate-resistant strain of Lactobacillus casei. Biochem J (1976) 1.24
Protein-ligand interactions: exchange processes and determination of ligand conformation and protein-ligand contacts. Methods Enzymol (1994) 1.22
Kinetic aspects of structure-activity relations: the binding of sulphonamides by carbonic anhydrase. Proc R Soc Lond B Biol Sci (1976) 1.22
Direct measurement of the pK values of an alkaline Bohr group in human hemoglobin. Proc Natl Acad Sci U S A (1973) 1.21
Nuclear magnetic resonance studies of the structure and binding sites of enzymes. 8. Inhibitor binding to ribonuclease. J Mol Biol (1969) 1.21
Structure revision of the antibiotic echinomycin. J Am Chem Soc (1975) 1.21
Ca2+ coordination to backbone carbonyl oxygen atoms in calmodulin and other EF-hand proteins: 15N chemical shifts as probes for monitoring individual-site Ca2+ coordination. Biochemistry (1998) 1.20
The properties of muscarinic receptors in mammalian cerebral cortex. Br J Pharmacol (1974) 1.20
A study of the muscarinic receptor by gel electrophoresis. Br J Pharmacol (1979) 1.19
Relaxation of anaesthetics in the presence of cyto-membranes. Nature (1968) 1.19
Solution structure of the active domain of tissue inhibitor of metalloproteinases-2. A new member of the OB fold protein family. Biochemistry (1994) 1.18
Limited proteolysis and proton n.m.r. spectroscopy of the 2-oxoglutarate dehydrogenase multienzyme complex of Escherichia coli. Biochem J (1981) 1.18
Solution structures of nisin A and its two major degradation products determined by n.m.r. Biochem J (1992) 1.16
The drug-receptor complex. J Pharm Pharmacol (1966) 1.16
Conformational changes and drug action. Fed Proc (1981) 1.16
Two populations of binding sites for muscarinic antagonists in the rat heart. Eur J Pharmacol (1981) 1.14
Stopped-flow kinetic studies of flavin reduction in human cytochrome P450 reductase and its component domains. Biochemistry (2001) 1.13
31P-n.m.r. studies on cerebral energy metabolism under conditions of hypoglycaemia and hypoxia in vitro. Biochem J (1983) 1.13
The solution structure of the bovine S100B protein dimer in the calcium-free state. Structure (1996) 1.12
Thiomandelic acid, a broad spectrum inhibitor of zinc beta-lactamases: kinetic and spectroscopic studies. J Biol Chem (2001) 1.12
Role of transmembrane pH gradient and membrane binding in nisin pore formation. J Bacteriol (1997) 1.11
High resolution structure of the N-terminal domain of tissue inhibitor of metalloproteinases-2 and characterization of its interaction site with matrix metalloproteinase-3. J Biol Chem (1998) 1.11
Molecular analysis of the regulation of nisin immunity. Microbiology (1996) 1.10
Crystal structure of the FMN-binding domain of human cytochrome P450 reductase at 1.93 A resolution. Protein Sci (1999) 1.10
The effects of ions on the binding of agonists and antagonists to muscarinic receptors. Br J Pharmacol (1979) 1.10
Occupancy of muscarinic acetylcholine receptors stimulates a guanylate cyclase in neuroblastoma cells. Biochem Soc Trans (1977) 1.09
Structure-activity relationships in the peptide antibiotic nisin: antibacterial activity of fragments of nisin. FEBS Lett (1996) 1.08
Structure-activity relationships in flexible protein domains: regulation of rho GTPases by RhoGDI and D4 GDI. J Mol Biol (2001) 1.08
A model for human cytochrome P450 2D6 based on homology modeling and NMR studies of substrate binding. Biochemistry (1996) 1.08
Imaging of acute pyelonephritis in the adult. Eur Radiol (2006) 1.08
Ligand-binding propeties of the muscarinic acetylcholine receptor in mouse neuroblastoma cells. Biochem J (1978) 1.07
The effect of McN-A-343 on muscarinic receptors in the cerebral cortex and heart. Br J Pharmacol (1983) 1.06
A modulator of rho family G proteins, rhoGDI, binds these G proteins via an immunoglobulin-like domain and a flexible N-terminal arm. Structure (1997) 1.06
The effects of p-chloromercuribenzoate on muscarinic receptors in the cerebral cortex. Br J Pharmacol (1983) 1.06
A kinetic study of wild-type and mutant dihydrofolate reductases from Lactobacillus casei. Biochemistry (1989) 1.06
High-resolution solution structure of human pNR-2/pS2: a single trefoil motif protein. J Mol Biol (1997) 1.06
Structure-activity relationships in the peptide antibiotic nisin: role of dehydroalanine 5. Appl Environ Microbiol (1996) 1.04
1H-NMR studies at 500 MHz of a neutral disaccharide and sulphated di-, tetra-, hexa- and larger oligosaccharides obtained by endo-beta-galactosidase treatment of keratan sulphate. Eur J Biochem (1986) 1.04
Canine reaginic antibody. Characterization of the spontaneous anti-ragweed and induced anti-dinitrophenyl reaginic antibodies of the atopic dog. Clin Exp Immunol (1971) 1.04
Antivasopressin antibody. Characterization of high-affinity rabbit antibody with limited association constant heterogeneity. Biochemistry (1969) 1.04
Sequential 1H NMR assignments and secondary structure of an IgG-binding domain from protein G. Biochemistry (1991) 1.03
Anti-HIV-1 activity of chemically modified heparins: correlation between binding to the V3 loop of gp120 and inhibition of cellular HIV-1 infection in vitro. Biochemistry (1994) 1.03
Equine antihapten antibody. The subunits and fragments of anti-beta-lactoside antibody. J Exp Med (1967) 1.02
The effect of p-chloromercuribenzoate on structure-binding relationships of muscarinic receptors in the rat cerebral cortex. Br J Pharmacol (1983) 1.02
Circular dichroism of hapten-antibody complexes: studies of tryptophanyl residue involvement in the antibody combining sites of MOPC-315 protein heavy and light chain subunits, reconstituted MOPC-315 protein and its FV-fragment. Immunochemistry (1976) 1.02
Homogeneous antibody elicited with dinitrophenyl-gramicidin-S (rabbit-isoelectric focusing). Proc Natl Acad Sci U S A (1972) 1.01
Binding of coenzyme analogues to Lactobacillus casei dihydrofolate reductase: binary and ternary complexes. Biochemistry (1980) 1.01
The effect of a respiratory home nurse intervention in patients with chronic obstructive pulmonary disease (COPD). Aust N Z J Med (1999) 1.01
The effects of calcium and magnesium on the response of intestine smooth muscle to drugs. Br J Pharmacol (1970) 1.01
Kinetics of complex formation between human carbonic anhydrases and aromatic sulfonamides. Biochemistry (1970) 1.01
Determination of the solution structures of domains II and III of protein G from Streptococcus by 1H nuclear magnetic resonance. J Mol Biol (1992) 1.00
NMR studies of substrate binding to cytochrome P450 BM3: comparisons to cytochrome P450 cam. Biochemistry (1995) 1.00
Proton nuclear magnetic resonance study of the self-complementary hexanucleotide d(pTpA)3 and its interaction with daunomycin. Biochemistry (1980) 1.00
Expression of deuterium-isotope-labelled protein in the yeast pichia pastoris for NMR studies. J Biomol NMR (2000) 0.99
Mechanism of lantibiotic-induced pore-formation. Antonie Van Leeuwenhoek (1996) 0.99
Association of Perthes' disease with congenital anomalies of genitourinary tract and inguinal region. Lancet (1971) 0.99
Domain structure and 1H-n.m.r. spectroscopy of the pyruvate dehydrogenase complex of Bacillus stearothermophilus. Biochem J (1984) 0.99